LUMOS PHARMA, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Lumos Pharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q4 2019 to Q4 2023.
  • Lumos Pharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending December 31, 2023 was $332K, a 40.7% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $332K +$96K +40.7% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $236K -$101K -30% Dec 31, 2022 10-K 2023-03-07
Q4 2021 $337K +$59K +21.2% Dec 31, 2021 10-K 2022-03-11
Q3 2021 $337K +$59K +21.2% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $337K Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $117K Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $278K -$321K -53.6% Dec 31, 2020 10-K 2021-03-09
Q3 2020 $278K Sep 30, 2020 10-Q 2020-11-12
Q4 2019 $599K Dec 31, 2019 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.